Market Research Report
Latin America, Middle East & Africa Orthopedic Biomaterials Market (2019-2025)
|Published by||KBV Research||Product code||914141|
|Published||Content info||75 Pages
Delivery time: 1-2 business days
|Latin America, Middle East & Africa Orthopedic Biomaterials Market (2019-2025)|
|Published: September 30, 2019||Content info: 75 Pages||
The Latin America, Middle East and Africa Orthopedic Biomaterials Market would witness market growth of 11.2% CAGR during the forecast period (2019-2025). Factors like the world's increasing population and urbanization promote market growth. Improving the financial situation enables access to a high-quality lifestyle and improved healthcare induces business growth. The main participants in the industry pay off well to boost market growth by making seminal efforts to develop revolutionary biomaterials. Government projects also play an important part in promoting market growth.
The orthopedic diseases are rising in bone injuries like arthritis, rheumatoid arthritis, osteoarthritis, osteoporosis, and serious limb trauma. The global pressure of musculoskeletal disease in developing and underdeveloped economies is extensive, growing, and neglected. Although considerable funding is available for the control of communicable disease, the prevention or treatment of orthopedic problems in developing regions has received little attention.
Based on Material Type, the market is segmented into Emergency Care, Short-Term Stabilization, Trauma Care, Acute care surgery and Other Conditions. Based on Application, the market is segmented into Orthopedic Implants, Joint Replacements, Bio-resorbable Tissue Fixation, Orthobiologics and Visco Supplementation. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Zimmer Biomet Holdings, Inc., Stryker Corporation, Victrex PLC (Invibio Ltd.), Globus Medical, Inc., CAM Bioceramics B.V., Heraeus Holding GmbH, Exactech, Inc., Collagen Matrix, Inc., Evonik Industries AG and Koninklijke DSM N.V. (DSM Biomedical B.V.).